Assignee
HEDGEPATH PHARMACEUTICALS INC
US·4 granted patents·6 pending applications·1 citations·filing 2015–2019
Top patents by PatentIndex Score
10 records- 0177US9968600B2Treatment and prognostic monitoring of non-cancerous proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·1 cites·19 claims
- 0268US2019255044A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0368US2019255045A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0467US10363252B2Treatment of prostate cancer using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2018·Granted Jul 30, 2019·0 cites·20 claims
- 0567US10328072B2Treatment of lung cancer using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·24 claims
- 0664US9962381B2Treatment and prognostic monitoring of cancerous proliferation disorders using Hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2017·Granted May 8, 2018·0 cites·21 claims
- 0759US2016074392A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0859US2016074393A1Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitorsHEDGEPATH PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0948US2019365743A1Hedgehog pathway inhibition for treatment of high-risk basal cell carcinoma or high-risk basal cell carcinoma nevus syndromeHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1048US2019365742A1Azole treatment regimen with reduced hepatotoxicityHEDGEPATH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HEDGEPATH PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →